The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combined analysis of circulating tumor cells and PSMA imaging metrics to predict efficacy of 177Lu-PSMA-617 in metastatic prostate cancer.
 
Yoshiyuki Miyazawa
No Relationships to Disclose
 
Arda Könik
Employment - Dana-Farber Cancer Institute
 
Zoe Guan
No Relationships to Disclose
 
Ibrahim Chamseddine
No Relationships to Disclose
 
Keisuke Otani
No Relationships to Disclose
 
Yukako Otani
No Relationships to Disclose
 
Rea Pittie
Employment - Massachusetts General Hospital
 
Ella Chung
No Relationships to Disclose
 
Daniel Rodden
No Relationships to Disclose
 
Linda Nieman
No Relationships to Disclose
 
Katherine Xu
No Relationships to Disclose
 
Mythreayi Shan
No Relationships to Disclose
 
Richard Lee
Consulting or Advisory Role - exelixis; Janssen Oncology
Research Funding - Janssen
Expert Testimony - Boehringer Ingelheim
 
Xin Gao
Consulting or Advisory Role - ADC Therapeutics; Arvinas; Bayer; Flare Therapeutics; Hinova Pharmaceuticals; Loxo/Lilly
Research Funding - ALX Oncology (Inst); Aprea Therapeutics (Inst); Aravive (Inst); Arvinas (Inst); Bayer (Inst); Exelixis (Inst); Harpoon therapeutics (Inst); Loxo/Lilly (Inst); Merck (Inst); Novartis (Inst); Nuvation Bio (Inst); Pfizer (Inst); Poseida therapeutics (Inst); Regeneron (Inst); Takeda (Inst); TopAlliance BioSciences Inc (Inst)
 
Pedram Heidari
No Relationships to Disclose
 
Dejan Juric
Stock and Other Ownership Interests - PIC Therapeutics; Relay Therapeutics; Vibliome Therapeutics
Consulting or Advisory Role - AstraZeneca; Eisai; Genentech; Lilly; MapKure; Novartis; Pfizer; PIC Therapeutics; Relay Therapeutics; Vibliome Therapeutics
Research Funding - Amgen (Inst); Arvinas (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Eisai (Inst); Genentech (Inst); Infinity Pharmaceuticals (Inst); Infinity Pharmaceuticals (Inst); InventisBio (Inst); Novartis (Inst); Pfizer (Inst); Ribon Therapeutics (Inst); Scorpion Therapeutics; Syros Pharmaceuticals (Inst); Takeda (Inst); Takeda (Inst)
 
Miles Miller
No Relationships to Disclose
 
Thomas Ng
Stock and Other Ownership Interests - Telix Pharmaceuticals
Research Funding - Bayer
 
David Miyamoto
No Relationships to Disclose